Tandem Diabetes Care, Inc. (TNDM) Current Ratio
- Current ratio · latest quarter: Value 3.18×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.18× | Current assets / current liabilities. $804.64M ÷ $253.00M ≈ 3.18× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 804.64M USD | Assets, Current |
| Current obligations | 253.00M USD | Liabilities, Current |
| Cash and equivalents | 62.82M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Debt Securities, Available-for-sale, Current |
| Customer receivables | 162.06M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 135.11M USD | Inventory, Net |
| Payables | 64.13M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $804.64M | $253.00M | $62.82M | (m) | $162.06M | $135.11M | $64.13M | (m) | 3.18× |
| 2026-03-31 | $887.10M | $247.96M | $179.32M | (m) | $140.67M | $126.40M | $59.86M | (m) | 3.58× |
| 2025-12-31 | $618.14M | $242.72M | $90.63M | (m) | $165.49M | $128.77M | $47.07M | (m) | 2.55× |
| 2025-09-30 | $616.94M | $252.54M | $91.95M | (m) | $125.94M | $137.28M | $47.48M | (m) | 2.44× |
| 2025-06-30 | $614.82M | $251.69M | $64.11M | (m) | $128.44M | $142.57M | $55.84M | (m) | 2.44× |
| 2025-03-31 | $663.43M | $288.18M | $53.57M | (m) | $126.56M | $141.16M | $59.80M | (m) | 2.30× |
| 2024-12-31 | $724.49M | $247.05M | $69.23M | (m) | $114.58M | $149.61M | $44.73M | (m) | 2.93× |
| 2024-09-30 | $752.83M | $259.28M | $49.04M | (m) | $107.19M | $152.44M | $48.75M | $40.60M | 2.90× |
| 2024-06-30 | $733.39M | $240.61M | $47.70M | (m) | $98.12M | $161.66M | $47.78M | $40.54M | 3.05× |
| 2024-03-31 | $735.19M | $192.97M | $58.98M | (m) | $92.97M | $153.89M | $48.14M | (m) | 3.81× |
| 2023-12-31 | $747.99M | $195.26M | $58.87M | (m) | $105.56M | $157.94M | $49.59M | $0.00 | 3.83× |
| 2023-09-30 | $758.14M | $187.11M | $79.61M | (m) | $100.32M | $143.49M | $46.14M | (m) | 4.05× |
| 2023-06-30 | $764.30M | $174.66M | $130.75M | (m) | $98.71M | $147.60M | $57.08M | (m) | 4.38× |
| 2023-03-31 | $757.92M | $171.16M | $127.76M | (m) | $91.39M | $131.56M | $55.23M | (m) | 4.43× |
| 2022-12-31 | $849.98M | $165.29M | $172.52M | (m) | $114.72M | $111.12M | $55.73M | (m) | 5.14× |
| 2022-09-30 | $834.30M | $173.63M | $123.79M | (m) | $112.81M | $104.77M | $61.53M | (m) | 4.81× |
| 2022-06-30 | $835.04M | $139.26M | $114.97M | (m) | $103.76M | $88.10M | $50.66M | (m) | 6.00× |
| 2022-03-31 | $818.46M | $131.81M | $93.68M | (m) | $94.13M | $79.99M | $45.34M | (m) | 6.21× |
| 2021-12-31 | $811.52M | $131.86M | $71.18M | (m) | $110.72M | $68.55M | $28.03M | (m) | 6.15× |
| 2021-09-30 | $754.95M | $119.65M | $112.38M | (m) | $87.46M | $65.73M | $26.97M | (m) | 6.31× |
| 2021-06-30 | $698.28M | $108.72M | $98.58M | (m) | $80.21M | $66.70M | $27.50M | (m) | 6.42× |
| 2021-03-31 | $661.70M | $103.41M | $120.79M | (m) | $73.67M | $66.82M | $28.18M | (m) | 6.40× |
| 2020-12-31 | $637.24M | $103.85M | $94.61M | (m) | $82.19M | $63.72M | $17.80M | (m) | 6.14× |
| 2020-09-30 | $592.29M | $105.51M | $129.48M | (m) | $52.10M | $70.64M | $20.50M | (m) | 5.61× |
| 2020-06-30 | $539.68M | $114.31M | $222.48M | (m) | $45.03M | $62.26M | $16.37M | (m) | 4.72× |
| 2020-03-31 | $280.87M | $99.65M | $74.48M | (m) | $53.96M | $60.47M | $21.78M | (m) | 2.82× |
| 2019-12-31 | $276.14M | $99.40M | $51.17M | (m) | $46.59M | $49.07M | $17.75M | (m) | 2.78× |
| 2019-09-30 | $246.60M | $100.27M | $46.06M | $110.89M | $45.33M | $40.73M | $16.31M | (m) | 2.46× |
| 2019-06-30 | $213.16M | $84.21M | $38.16M | (m) | $48.44M | $27.34M | $9.27M | (m) | 2.53× |
| 2019-03-31 | $186.03M | $76.68M | $40.45M | (m) | $33.03M | $22.83M | $11.21M | (m) | 2.43× |
| 2018-12-31 | $187.88M | $66.29M | $41.83M | $87.20M | $35.19M | $19.90M | $6.82M | (m) | 2.83× |
| 2018-09-30 | $162.67M | $58.55M | $32.33M | (m) | $21.69M | $24.37M | $6.20M | (m) | 2.78× |
| 2018-06-30 | $128.34M | $42.51M | $50.55M | (m) | $13.91M | $24.91M | $3.65M | (m) | 3.02× |
| 2018-03-31 | $114.34M | $43.71M | $62.58M | (m) | $13.04M | $26.49M | $3.75M | (m) | 2.62× |
| 2017-12-31 | $64.16M | $36.09M | $13.70M | (m) | $20.79M | $26.99M | $5.15M | (m) | 1.78× |
| 2017-09-30 | $55.99M | $29.41M | $12.08M | (m) | $10.58M | $29.98M | $7.61M | (m) | 1.90× |
| 2017-06-30 | $65.13M | $30.84M | $27.35M | (m) | $9.03M | $25.82M | $6.62M | (m) | 2.11× |
| 2017-03-31 | $79.93M | $29.21M | $40.33M | (m) | $7.69M | $23.75M | $4.89M | (m) | 2.74× |
| 2016-12-31 | $92.09M | $31.48M | $44.68M | (m) | $11.17M | $21.20M | $7.51M | (m) | 2.93× |
| 2016-09-30 | $70.99M | $34.82M | $17.96M | (m) | $8.20M | $22.90M | $5.61M | (m) | 2.04× |
| 2016-06-30 | $90.88M | $27.07M | $30.25M | (m) | $9.43M | $21.69M | $6.84M | (m) | 3.36× |
| 2016-03-31 | $102.57M | $24.82M | $40.61M | (m) | $9.09M | $20.20M | $5.97M | (m) | 4.13× |
| 2015-12-31 | $106.98M | $26.52M | $43.09M | (m) | $14.05M | $17.54M | $5.23M | (m) | 4.03× |
| 2015-09-30 | $110.92M | $22.32M | $43.20M | (m) | $7.01M | $17.55M | $4.02M | (m) | 4.97× |
| 2015-06-30 | $124.06M | $18.48M | $45.92M | (m) | $7.47M | $14.67M | $4.00M | (m) | 6.71× |
| 2015-03-31 | $139.15M | $18.77M | $62.55M | (m) | $5.23M | $13.58M | $4.09M | (m) | 7.41× |
| 2014-12-31 | $90.75M | $18.09M | $31.18M | (m) | $7.65M | $11.91M | $1.95M | (m) | 5.02× |
| 2014-09-30 | $101.05M | $15.66M | $35.56M | (m) | $5.84M | $11.89M | $3.05M | (m) | 6.45× |
| 2014-06-30 | $114.42M | $13.21M | $64.21M | (m) | $4.36M | $11.12M | $2.52M | (m) | 8.66× |
| 2014-03-31 | $128.36M | $13.14M | $76.83M | (m) | $3.42M | $10.16M | $2.05M | (m) | 9.77× |
| 2013-12-31 | $148.99M | $14.60M | $124.39M | (m) | $5.30M | $10.33M | $2.35M | (m) | 10.21× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |